Who owns ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1?
- CUSIP Number: 02043qab3
Tip: Access positions for across all investors
Analyze quarterly positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alnylam Pharmaceuticals Inc Note 1.000 9/1 stock
Who bought or sold ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 151M | $161M | -14% | Dec 2024 |
|
| Deerfield Management Company | 110M | $117M | 10% | Dec 2024 |
|
| Highbridge Capital Management | 80M | $86M | 100% | Dec 2024 |
|
| Davidson Kempner Capital Management | 55M | $59M | 22% | Dec 2024 |
|
| Aequim Alternative Investments | 50M | $53M | -38% | Dec 2024 |
|
| Lazard Asset Management | 48M | $51M | -18% | Dec 2024 |
|
| Invesco | 46M | $49M | 2% | Dec 2024 |
|
| Calamos Advisors | 41M | $44M | -20% | Dec 2024 |
|
| BlackRock | 35M | $37M | -39% | Dec 2024 |
|
| FMR | 30M | $32M | -2% | Dec 2024 |
|
| Nuveen Asset Management | 26M | $28M | 100% | Dec 2024 |
|
| DeepCurrents Investment Group | 23M | $25M | 1% | Dec 2024 |
|
| State Street Corporation | 23M | $25M | 6% | Dec 2024 |
|
| Wellington Management Company | 19M | $20M | 2% | Dec 2024 |
|
| Shenkman Capital Management | 16M | $17B | 11% | Dec 2024 |
|
| MacKay Shields | 15M | $16M | -2% | Dec 2024 |
|
| Zazove Associates | 12M | $13M | 100% | Dec 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12M | $13M | 0% | Dec 2024 |
|
| Morgan Stanley | 11M | $12M | -23% | Dec 2024 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 10M | $11M | 100% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 7.8M | $8.2M | 9% | Dec 2024 |
|
| Capstone Investment Advisors | 7.5M | $8.0M | 0% | Dec 2024 |
|
| Silverback Asset Management | 7.5M | $8.0B | 100% | Dec 2024 |
|
| SSI Investment Management | 7.1M | $7.5M | -4% | Dec 2024 |
|
| Ameriprise Financial | 7.0M | $7.4M | 17% | Dec 2024 |
|
| Franklin Resources | 6.7M | $7.2M | 15% | Dec 2024 |
|
| Steelhead Partners | 6.5M | $6.9B | 100% | Dec 2024 |
|
| Walleye Trading Advisors | 5.0M | $5.3M | 100% | Dec 2024 |
|
| Bnp Paribas Investment Partners | 5.0M | $5.3M | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 4.3M | $4.6M | 31% | Dec 2024 |
|
| RWC Asset Management | 4.1M | $4.4M | 0% | Dec 2024 |
|
| Angelo, Gordon & Co | 3.5M | $3.7M | 100% | Dec 2024 |
|
| Axa | 3.3M | $3.5M | -7% | Dec 2024 |
|
| Amundi | 3.2M | $3.4M | 0% | Dec 2024 |
|
| Man Group | 3.2M | $3.4M | 0% | Dec 2024 |
|
| Toronto-Dominion Bank | 3.0M | $3.2M | 100% | Dec 2024 |
|
| Alberta Investment Management Corporation | 2.5M | $2.7M | 100% | Dec 2024 |
|
| Royal Bank of Canada | 2.0M | $2.1M | -37% | Dec 2024 |
|
| Barclays | 1.9M | $2.1M | -62% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.7M | $1.8M | 100% | Dec 2024 |
|
| Leucadia National Corporation | 1.7M | $1.8M | 100% | Dec 2024 |
|
| Ubs Global Asset Management Americas | 1.4M | $1.5M | -3% | Dec 2024 |
|
| Oaktree Capital Management | 1.4M | $1.4M | -25% | Dec 2024 |
|
| Wells Fargo & Company | 761k | $813k | -75% | Dec 2024 |
|
| Bank Of Montreal | 695k | $658k | -59% | Dec 2024 |
|
| Zurcher Kantonalbank | 500k | $534k | 0% | Dec 2024 |
|
| Bank of New York Mellon | 500k | $534k | -17% | Dec 2024 |
|
| Central Pacific Bank - Trust Division | 398k | $423k | 0% | Dec 2024 |
|
| Russell Investments | 393k | $421k | -27% | Dec 2024 |
|
| KBC Group NV | 300k | $322k | 0% | Dec 2024 |
|
| First Hawaiian Bank | 115k | $122k | 0% | Dec 2024 |
|
| Sei Investments | 99k | $105k | 0% | Dec 2024 |
|
| Bank of America Corporation | 95k | $101k | -99% | Dec 2024 |
|
| Calamos Wealth Management | 81k | $87k | -17% | Dec 2024 |
|
| Oppenheimer Asset Management | 78k | $83k | -8% | Dec 2024 |
|
| Lake Street Advisors Group | 51k | $54k | 0% | Dec 2024 |
|
| Virtus Investment Advisers | 47k | $50k | 0% | Dec 2024 |
|
| Stephens | 22k | $23k | -49% | Dec 2024 |
|
| Balboa Wealth Partners | 17k | $18k | 0% | Dec 2024 |
|
| Boussard & Gavaudan Investment Management | 6.5k | $7.0M | -38% | Dec 2024 |
|
| EverSource Wealth Advisors | 3.0k | $3.2k | 0% | Dec 2024 |
|
| Steward Partners Investment Advisory | 2.0k | $2.1k | 100% | Dec 2024 |
|
| Us Bancorp | 2.0k | $2.1k | 0% | Dec 2024 |
|
| Candriam Luxembourg S.C.A. | 520.00 | $557k | 0% | Dec 2024 |
|
Who sold out of Alnylam Pharmaceuticals Inc Note 1.000 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2024 | 20M | $24M |
| Lombard Odier Asset Management | Sep 2024 | 12M | $14M |
| Verition Fund Management | Sep 2024 | 6.6M | $7.7M |
| Citigroup | Sep 2024 | 4.0M | $4.7M |
| Polar Capital Holdings | Jun 2024 | 4.0M | $4.3M |
| Ghisallo Capital Management | Jun 2024 | 2.5M | $2.7M |
| Groupama Asset Managment | Jun 2024 | 1.5M | $1.6M |
| CNH Partners | Sep 2024 | 130k | $152k |
| Nomura Holdings | Sep 2024 | 72k | $20M |